Malaysia
Search
Sign In
Change Password
Points
Sign Out
Psychiatry
Top Medical News
The second-generation antipsychotic amisulpride performs well in the treatment of depression and associated symptoms in individuals with a major mental health disorder, with efficacy and tolerability profiles similar to those of selective serotonin reuptake inhibitors and tricyclic antidepressants, as suggested in a meta-analysis of randomized controlled trials.
New drug applications approved by US FDA as of 01-15 June 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Most young people in Singapore regard depressive disorders as a “reduced state of being” due to living a life that falls short of often unrealistic societal expectations, according to a recent study.
Antidepressants remain the most understood treatment modality for depression after coronary artery disease (CAD), though emerging evidence suggests that combining them with psychotherapy and exercise seems to improve effectiveness, according to a recent network meta-analysis.
The opioid antagonist naltrexone helps reduce symptoms in patients with borderline personality disorder, with the effect dictated by dose and superior to all available psychoactive drugs, as shown in a study.
Patients with obsessive-compulsive disorder are at heightened risk of developing new-onset ischaemic stroke later in life, a study reports.
Closed-circuit television (CCTV) and video systems have seen growing use in the prevention of suicide, particularly for the early detection of preattempts, according to a new study.
Special Reports
The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illness. On the first day, eminent local and internationalexperts weighed in on the treatment of major depressive disorder (MDD), including in the elderly and incases of coexisting anxiety.
The Lundbeck Neuroscience Symposium was held at Sofitel KL Damansara over 2 days, with extensivediscussions on the management of various mental illnesses. The second day of the symposiumaddressed the topic of schizophrenia management, focusing on treatment goals, the rationale forpartial dopamine D(2) receptor agonism and the use of long-acting injectable (LAI) antipsychotics topromote adherence.
On 6 November 2016, in conjunction with the first year anniversary of vortioxetine (Brintellix®, Lundbeck) in Malaysia, two distinguished speakers, Professor Gin S Malhi and Dr Pranab Kalita shared updates on depression and the use of vortioxetine in order to help patients with major depressive disorders (MDD) to return to their premorbid functional states. The session was followed by three case presentations.
Conference Reports
For children, being at the receiving end of online bullying makes them 12 times more susceptible to suicidal thoughts and actions, with the risk exacerbated by increased use of social media, as shown in the results of a meta-analysis presented at the virtual American Psychiatric Association (APA) 2021 Annual Meeting.
Bright light therapy done at midday may be an effective and affordable adjunct to antimanic medication in patients with bipolar depression (BD), according to an expert who presented at APA 2021. This brings renewed attention to this natural, somatic treatment primarily used for seasonal depression.
Anxiety symptoms in patients with mild cognitive impairment (MCI) may increase their risk of developing Alzheimer’s disease, according to a study presented at the Radiological Society of North America annual meeting (RSNA 2020).
Multidomain intervention which includes nutrition, exercise, cognitive training and vascular risk monitoring is effective in preventing dementia, findings from the FINGER study have shown.
_1_2_Square.jpg)
Use of a ginkgo biloba extract on top of standard preventive treatment is shown to improve cognitive function and overall condition after acute ischaemic stroke.